stockrowDoximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) EPS (diluted)
Doximity, Inc.'s EPS (diluted) for fiscal 2026 was $0.98, down 11.7% from $1.11 in fiscal 2025. Over the twelve months to 30 September 2026 it was $0.72. Over the past ten years it has ranged from $0.10 (fiscal 2019) to $1.11 (fiscal 2025); the current reading is higher than 88% of that period. Doximity, Inc. ranks 8th of 42 Health Information Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $0.98 | (11.71%) |
| FY2025 | $1.11 | 54.17% |
| FY2024 | $0.72 | 35.85% |
| FY2023 | $0.53 | (24.29%) |
| FY2022 | $0.70 | 204.35% |
| FY2021 | $0.23 | 76.92% |
| FY2020 | $0.13 | 25.60% |
| FY2019 | $0.10 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.18 | 38.46% |
| Jun 2026 | $0.13 | 30.00% |
| Mar 2026 | $0.10 | (67.74%) |
| Dec 2025 | $0.31 | 0.00% |
| 23 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| HQY HealthEquity, Inc. compare | $2.77 |
| BTSG BrightSpring Health Services, Inc. compare | $1.85 |
| HNGE Hinge Health Inc. compare | $1.28 |
| DOCS Doximity, Inc. | $0.72 |
| WAY Waystar Holding Corp. compare | $0.69 |
| PRVA Privia Health Group, Inc. compare | $0.27 |
| SDGR Schrodinger, Inc. compare | −$0.79 |
| TEM Tempus AI, Inc. compare | −$1.06 |
| HTFL Heartflow, Inc. compare | −$1.83 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on DOCS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement